JP2011530592A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011530592A5 JP2011530592A5 JP2011522953A JP2011522953A JP2011530592A5 JP 2011530592 A5 JP2011530592 A5 JP 2011530592A5 JP 2011522953 A JP2011522953 A JP 2011522953A JP 2011522953 A JP2011522953 A JP 2011522953A JP 2011530592 A5 JP2011530592 A5 JP 2011530592A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- membrane
- composition
- conductivity
- ion exchange
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 34
- 239000012528 membrane Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 239000000872 buffer Substances 0.000 claims description 8
- 239000003014 ion exchange membrane Substances 0.000 claims description 4
- 239000003011 anion exchange membrane Substances 0.000 claims description 2
- 238000005341 cation exchange Methods 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims 6
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 2
- 238000004255 ion exchange chromatography Methods 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims 1
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims 1
- 241000699802 Cricetulus griseus Species 0.000 claims 1
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims 1
- 102000002259 TNF-Related Apoptosis-Inducing Ligand Receptors Human genes 0.000 claims 1
- 108010000449 TNF-Related Apoptosis-Inducing Ligand Receptors Proteins 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 108091008605 VEGF receptors Proteins 0.000 claims 1
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 claims 1
- 239000003463 adsorbent Substances 0.000 claims 1
- 238000001042 affinity chromatography Methods 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 229960000397 bevacizumab Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 1
- 229960000470 omalizumab Drugs 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 229960002087 pertuzumab Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 229960004641 rituximab Drugs 0.000 claims 1
- 229960000575 trastuzumab Drugs 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 description 19
- 102000004196 processed proteins & peptides Human genes 0.000 description 19
- 108090000765 processed proteins & peptides Proteins 0.000 description 19
- 239000000356 contaminant Substances 0.000 description 6
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2008/073179 WO2010019148A1 (en) | 2008-08-14 | 2008-08-14 | Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011530592A JP2011530592A (ja) | 2011-12-22 |
| JP2011530592A5 true JP2011530592A5 (enExample) | 2014-06-26 |
| JP5666447B2 JP5666447B2 (ja) | 2015-02-12 |
Family
ID=39899038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011522953A Active JP5666447B2 (ja) | 2008-08-14 | 2008-08-14 | 常在性タンパク質置換イオン交換メンブレンクロマトグラフィを用いた混入物除去方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US10927144B2 (enExample) |
| EP (3) | EP2321337B2 (enExample) |
| JP (1) | JP5666447B2 (enExample) |
| KR (3) | KR101843915B1 (enExample) |
| CN (1) | CN102149724B (enExample) |
| AU (1) | AU2008360625C1 (enExample) |
| BR (1) | BRPI0823046B1 (enExample) |
| CA (1) | CA2731943C (enExample) |
| CY (1) | CY1122221T1 (enExample) |
| DK (2) | DK3604324T3 (enExample) |
| ES (3) | ES2527943T5 (enExample) |
| FI (1) | FI3604324T3 (enExample) |
| HR (2) | HRP20240472T1 (enExample) |
| HU (2) | HUE047316T2 (enExample) |
| IL (2) | IL210912B (enExample) |
| LT (2) | LT2848625T (enExample) |
| MX (1) | MX2011001506A (enExample) |
| PL (2) | PL2848625T3 (enExample) |
| PT (2) | PT2848625T (enExample) |
| RS (1) | RS59232B1 (enExample) |
| SI (2) | SI3604324T1 (enExample) |
| WO (1) | WO2010019148A1 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2500413A1 (en) | 2006-09-13 | 2012-09-19 | Abbott Laboratories | Cell culture improvements |
| US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
| KR101843915B1 (ko) | 2008-08-14 | 2018-04-02 | 제넨테크, 인크. | 고유 단백질 대체 이온 교환 막 크로마토그래피를 이용한 오염물의 제거 방법 |
| KR20110091678A (ko) * | 2008-10-20 | 2011-08-12 | 아보트 러보러터리즈 | 단백질 ａ 친화성 크로마토그래피를 이용한 항체의 분리 및 정제 |
| NZ592097A (en) * | 2008-10-20 | 2013-01-25 | Abbott Lab | Viral inactivation during purification of il-12 and il-18 antibodies |
| MY161534A (en) † | 2010-05-25 | 2017-04-28 | Genentech Inc | Methods of purifying polypeptides |
| WO2012030512A1 (en) * | 2010-09-03 | 2012-03-08 | Percivia Llc. | Flow-through protein purification process |
| WO2012077080A1 (en) * | 2010-12-10 | 2012-06-14 | Tracy Thompson | Compositions for separation methods |
| EP2702077A2 (en) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| IL267585B (en) * | 2011-12-22 | 2022-09-01 | Genentech Inc | Ion exchange membrane chromatography |
| WO2013158279A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Protein purification methods to reduce acidic species |
| WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| SG11201505203XA (en) * | 2013-02-26 | 2015-08-28 | Agency Science Tech & Res | Protein purification in the presence of nonionic organic polymers and electropositive surfaces |
| CA2905010A1 (en) | 2013-03-12 | 2014-09-18 | Abbvie Inc. | Human antibodies that bind human tnf-alpha and methods of preparing the same |
| US10023608B1 (en) | 2013-03-13 | 2018-07-17 | Amgen Inc. | Protein purification methods to remove impurities |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
| JP6163541B2 (ja) * | 2013-04-16 | 2017-07-12 | 旭化成メディカル株式会社 | 抗体タンパク質の精製方法 |
| US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| EP2986307A4 (en) | 2014-01-03 | 2017-04-12 | Bio-rad Laboratories, Inc. | Removal of impurities from protein a eluates |
| CA3035853A1 (en) * | 2016-09-07 | 2018-03-15 | Glaxosmithkline Intellectual Property Development Limited | Methods for purifying antibodies |
| EP3509729A1 (en) | 2016-09-09 | 2019-07-17 | 3M Innovative Properties Company | Functionalized copolymers and use thereof |
| US10053368B1 (en) * | 2017-09-07 | 2018-08-21 | Chevron U.S.A. Inc. | Synthesis of AFX framework type molecular sieves |
| EP3546475A1 (en) * | 2018-03-27 | 2019-10-02 | Sanofi | Full flow-through process for purifying recombinant proteins |
| TWI814812B (zh) * | 2018-05-02 | 2023-09-11 | 美商里珍納龍藥品有限公司 | 用於評估生化過濾器的適合性的方法 |
| EP3810650A1 (en) * | 2018-06-19 | 2021-04-28 | Bristol-Myers Squibb Company | Methods of purifying proteins using chromatography |
| CN109324143B (zh) * | 2018-10-19 | 2021-10-29 | 张骐 | 利用二维液相分离制备抗体类产品相关杂质的方法 |
| CN109806916B (zh) * | 2019-03-15 | 2021-12-21 | 中科森辉微球技术（苏州）有限公司 | 高性能阴离子交换介质及其制备方法 |
| GB201911685D0 (en) * | 2019-08-15 | 2019-10-02 | Fujifilm Diosynth Biotechnologies Uk Ltd | Process for purifying monoclonal antibodies |
| KR20220112014A (ko) | 2021-02-03 | 2022-08-10 | 고인석 | 십전대보탕을 이용하여 만든 오리목뼈 간식 |
| CA3236213A1 (en) * | 2021-10-27 | 2023-05-04 | Eugene ZURLO | Compositions and methods for isolating proteins |
| CN118290514B (zh) * | 2024-06-05 | 2025-04-04 | 东曜药业有限公司 | 基于阴离子膜的抗体偶联药物的纯化方法及抗体偶联药物 |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4515893A (en) | 1979-04-26 | 1985-05-07 | Ortho Pharmaceutical Corporation | Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells |
| US4347322A (en) † | 1981-01-12 | 1982-08-31 | Nabisco Brands, Inc. | Chromatographic process for enzyme purification |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US5091178A (en) | 1986-02-21 | 1992-02-25 | Oncogen | Tumor therapy with biologically active anti-tumor antibodies |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| US5091313A (en) | 1988-08-05 | 1992-02-25 | Tanox Biosystems, Inc. | Antigenic epitopes of IgE present on B cell but not basophil surface |
| US5720937A (en) | 1988-01-12 | 1998-02-24 | Genentech, Inc. | In vivo tumor detection assay |
| WO1989012463A1 (en) | 1988-06-21 | 1989-12-28 | Genentech, Inc. | Method and therapeutic compositions for the treatment of myocardial infarction |
| EP0435911B1 (en) | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| ES2193136T3 (es) | 1991-08-14 | 2003-11-01 | Genentech Inc | Variantes de inmunoglubina para receptores especificos de fc epsilon. |
| AU3178993A (en) | 1991-11-25 | 1993-06-28 | Enzon, Inc. | Multivalent antigen-binding proteins |
| ATE419355T1 (de) | 1992-02-06 | 2009-01-15 | Novartis Vaccines & Diagnostic | Marker für krebs und biosynthetisches bindeprotein dafür |
| EP0656789B1 (en) | 1992-08-21 | 1997-12-17 | Genentech, Inc. | Method for treating a lfa-1-mediated disorder |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| US5595721A (en) | 1993-09-16 | 1997-01-21 | Coulter Pharmaceutical, Inc. | Radioimmunotherapy of lymphoma using anti-CD20 |
| CA2106612C (en) * | 1993-09-21 | 2001-02-06 | Diana Pliura | Displacement chromatography process |
| US5714338A (en) | 1993-12-10 | 1998-02-03 | Genentech, Inc. | Methods for diagnosis of allergy |
| EP0739214B1 (en) | 1994-01-18 | 1998-03-18 | Genentech, Inc. | A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS |
| EP0749488A1 (en) | 1994-03-03 | 1996-12-27 | Genentech, Inc. | Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders |
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| IL117645A (en) | 1995-03-30 | 2005-08-31 | Genentech Inc | Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration |
| AU6267896A (en) | 1995-06-07 | 1996-12-30 | Imclone Systems Incorporated | Antibody and antibody fragments for inhibiting the growth oftumors |
| EP1297847A3 (en) | 1996-01-23 | 2003-05-07 | Genentech, Inc. | Anti-CD18 antibodies in stroke |
| US6592905B1 (en) | 1996-01-31 | 2003-07-15 | Massey University | Production of an immunoglobulin enriched fraction from whey protein solutions |
| US7147851B1 (en) | 1996-08-15 | 2006-12-12 | Millennium Pharmaceuticals, Inc. | Humanized immunoglobulin reactive with α4β7 integrin |
| KR100532178B1 (ko) | 1996-11-27 | 2005-12-01 | 제넨테크, 인크. | 인간화 항-ＣＤ11ａ 항체 |
| ES2236634T3 (es) | 1997-04-07 | 2005-07-16 | Genentech, Inc. | Anticuerpos anti-vegf. |
| ES2293682T5 (es) | 1997-05-15 | 2011-11-17 | Genentech, Inc. | Anticuerpo anti-apo2. |
| ATE321066T1 (de) | 1998-05-06 | 2006-04-15 | Genentech Inc | Anti-her2 antikörperzusammensetzung |
| US6946129B1 (en) | 1999-06-08 | 2005-09-20 | Seattle Genetics, Inc. | Recombinant anti-CD40 antibody and uses thereof |
| DK1226177T3 (da) | 1999-10-29 | 2008-10-06 | Genentech Inc | Antistofsammensætninger mod anti-prostata stamcelle-antigen (PSCA) og anvendelser deraf |
| US6479636B1 (en) † | 2000-04-11 | 2002-11-12 | Honiron Corporation (A Louisiana Corporation) | Sugarcane fractioning system |
| US6633462B2 (en) | 2000-07-13 | 2003-10-14 | Koninklijke Philips Electronics N.V. | Magnetoresistive angle sensor having several sensing elements |
| UA83458C2 (uk) | 2000-09-18 | 2008-07-25 | Байоджен Айдек Ма Інк. | Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf) |
| GB2372464B (en) † | 2001-02-22 | 2003-05-14 | Vivascience Ltd | Method of isolating a charged compound |
| US7321026B2 (en) | 2001-06-27 | 2008-01-22 | Skytech Technology Limited | Framework-patched immunoglobulins |
| WO2003033658A2 (en) | 2001-10-17 | 2003-04-24 | Human Genome Sciences, Inc. | Neutrokine-alpha and neutrokine-alpha splice variant |
| US20040093621A1 (en) | 2001-12-25 | 2004-05-13 | Kyowa Hakko Kogyo Co., Ltd | Antibody composition which specifically binds to CD20 |
| CN100522999C (zh) | 2002-02-14 | 2009-08-05 | 免疫医疗公司 | 抗cd20抗体及其融合蛋白和使用方法 |
| JP4319979B2 (ja) † | 2002-04-26 | 2009-08-26 | ジェネンテック・インコーポレーテッド | タンパク質の非アフィニティ精製 |
| SI1561756T1 (sl) * | 2002-09-11 | 2016-02-29 | Chugai Seiyaku Kabushiki Kaisha | Postopek čiščenja proteinov |
| WO2004035607A2 (en) | 2002-10-17 | 2004-04-29 | Genmab A/S | Human monoclonal antibodies against cd20 |
| PT1572744E (pt) | 2002-12-16 | 2010-09-07 | Genentech Inc | Variantes de imunoglobulina e utilizações destas |
| NZ543960A (en) | 2003-05-09 | 2008-11-28 | Univ Duke | CD20-specific antibodies and methods of employing same |
| AR044388A1 (es) | 2003-05-20 | 2005-09-07 | Applied Molecular Evolution | Moleculas de union a cd20 |
| JP4818917B2 (ja) | 2003-08-08 | 2011-11-16 | イミューノメディクス、インコーポレイテッド | 腫瘍および罹患細胞のアポトーシスを誘発するための二重特異性抗体 |
| US8147832B2 (en) | 2003-08-14 | 2012-04-03 | Merck Patent Gmbh | CD20-binding polypeptide compositions and methods |
| AU2004286938B2 (en) † | 2003-10-27 | 2011-06-30 | Wyeth | Removal of high molecular weight aggregates using hydroxyapatite chromatography |
| CA2597265C (en) | 2005-02-10 | 2015-03-24 | Baylor Research Institute | Anti-interferon alpha monoclonal antibodies and methods for use |
| KR101482791B1 (ko) † | 2005-03-11 | 2015-01-21 | 와이어쓰 엘엘씨 | 약한 분배성 크로마토그래피법 |
| WO2007108955A1 (en) † | 2006-03-20 | 2007-09-27 | Medarex, Inc. | Protein purification |
| JP2010505874A (ja) * | 2006-10-03 | 2010-02-25 | ノヴォ ノルディスク アー／エス | ポリペプチドコンジュゲートの精製方法 |
| WO2009135656A1 (en) | 2008-05-06 | 2009-11-12 | Lonza Biologics Plc. | A method for the purification of antibodies using displacement chromatography |
| KR101843915B1 (ko) | 2008-08-14 | 2018-04-02 | 제넨테크, 인크. | 고유 단백질 대체 이온 교환 막 크로마토그래피를 이용한 오염물의 제거 방법 |
| JP5731726B1 (ja) | 2014-06-26 | 2015-06-10 | 楽天株式会社 | 情報処理装置、情報処理方法及び情報処理プログラム |
-
2008
- 2008-08-14 KR KR1020117005824A patent/KR101843915B1/ko active Active
- 2008-08-14 PL PL14189582T patent/PL2848625T3/pl unknown
- 2008-08-14 KR KR1020187036563A patent/KR102196883B1/ko active Active
- 2008-08-14 ES ES08797895T patent/ES2527943T5/es active Active
- 2008-08-14 EP EP08797895.3A patent/EP2321337B2/en active Active
- 2008-08-14 HU HUE14189582A patent/HUE047316T2/hu unknown
- 2008-08-14 ES ES14189582T patent/ES2749190T3/es active Active
- 2008-08-14 RS RSP20191119 patent/RS59232B1/sr unknown
- 2008-08-14 BR BRPI0823046-3A patent/BRPI0823046B1/pt active IP Right Grant
- 2008-08-14 EP EP14189582.1A patent/EP2848625B1/en active Active
- 2008-08-14 MX MX2011001506A patent/MX2011001506A/es active IP Right Grant
- 2008-08-14 ES ES19181531T patent/ES2978373T3/es active Active
- 2008-08-14 JP JP2011522953A patent/JP5666447B2/ja active Active
- 2008-08-14 KR KR1020187008461A patent/KR20180033311A/ko not_active Ceased
- 2008-08-14 HR HRP20240472TT patent/HRP20240472T1/hr unknown
- 2008-08-14 SI SI200832219T patent/SI3604324T1/sl unknown
- 2008-08-14 AU AU2008360625A patent/AU2008360625C1/en active Active
- 2008-08-14 PT PT141895821T patent/PT2848625T/pt unknown
- 2008-08-14 DK DK19181531.5T patent/DK3604324T3/da active
- 2008-08-14 SI SI200832092T patent/SI2848625T1/sl unknown
- 2008-08-14 US US13/058,796 patent/US10927144B2/en active Active
- 2008-08-14 FI FIEP19181531.5T patent/FI3604324T3/fi active
- 2008-08-14 EP EP19181531.5A patent/EP3604324B1/en active Active
- 2008-08-14 LT LTEP14189582.1T patent/LT2848625T/lt unknown
- 2008-08-14 LT LTEP19181531.5T patent/LT3604324T/lt unknown
- 2008-08-14 PL PL19181531.5T patent/PL3604324T3/pl unknown
- 2008-08-14 PT PT191815315T patent/PT3604324T/pt unknown
- 2008-08-14 WO PCT/US2008/073179 patent/WO2010019148A1/en not_active Ceased
- 2008-08-14 DK DK14189582.1T patent/DK2848625T3/da active
- 2008-08-14 CA CA2731943A patent/CA2731943C/en active Active
- 2008-08-14 CN CN200880131059.7A patent/CN102149724B/zh active Active
- 2008-08-14 HU HUE19181531A patent/HUE066562T2/hu unknown
-
2011
- 2011-01-27 IL IL210912A patent/IL210912B/en active IP Right Grant
-
2018
- 2018-10-28 IL IL262657A patent/IL262657B/en active IP Right Grant
-
2019
- 2019-10-11 CY CY20191101072T patent/CY1122221T1/el unknown
- 2019-10-14 HR HRP20191848TT patent/HRP20191848T1/hr unknown
-
2021
- 2021-01-20 US US17/153,826 patent/US20210284685A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011530592A5 (enExample) | ||
| EP3004163B1 (en) | Method for purifying antibody | |
| HRP20191848T1 (hr) | Postupci odstranjivanja kontaminanta uporabom membranske kromatografije ionskom izmjenom s premještanjem autohtonog proteina | |
| RU2014130017A (ru) | Способы повышения эффективности этапов очистки белка, находящихся ниже по потоку, с использованием мембранной ионообменной хроматографии | |
| TWI596107B (zh) | 單株抗體之新穎純化方法 | |
| FI3257564T4 (fi) | Ylikuormitus ja eluointikromatografia | |
| RU2016108828A (ru) | Способы и композиции, включающие очищенные рекомбинантные полипептиды | |
| NZ592094A (en) | Antibodies that bind to il-18 and methods of purifying the same | |
| JP2018184487A (ja) | 抗体を精製する方法 | |
| EP3337812B1 (en) | Method for the reduction of host cell proteins in affinity chromatography | |
| HRP20191342T1 (hr) | Anti-phf-tau antitijela i njihove upotrebe | |
| RU2006113695A (ru) | Удаление агрегатов с высокой молекулярной массой путем хроматографии на гидроксиапатитах | |
| JP2016530533A5 (enExample) | ||
| JP2016539176A5 (enExample) | ||
| JP6009431B2 (ja) | アフィニティー精製の方法 | |
| JP2017507657A5 (enExample) | ||
| RU2014111820A (ru) | Способы элиминации вируса | |
| RU2016137256A (ru) | АНТИТЕЛА К ФАКТОРУ КОМПЛЕМЕНТА Bb | |
| WO2017032610A1 (en) | Affinity chromatography purification with low conductivity wash buffer | |
| KR20210149089A (ko) | 사전 포획 응집을 이용하는 것에 의한 면역글로불린의 친화성 크로마토그래피 개선 | |
| WO2011038894A1 (en) | Protein a chromatography | |
| WO2005114218B1 (en) | Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule | |
| US20160347833A1 (en) | Antibody process | |
| CN113747960A (zh) | 用于再生色谱树脂的方法 | |
| CN113166200B (zh) | 一种提高蛋白a层析法去除聚集体的方法 |